The influence of citrate concentrations on PFA-100 closure times, platelet hyper-reactivity and aspirin monitoring.
Harrison
Paul
P
D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000378:metabolism*; D019343:Citric Acid / Q000378:metabolism*; D016903:Drug Monitoring; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests / Q000295:instrumentation / Q000379:methods*
D010975:Platelet Aggregation Inhibitors; D019343:Citric Acid; D001241:Aspirin